|
|
|
| Effect of Enteral Spray of Kuijieling on the Intestinal Mucosal Immune Function and Levels of Inflammatory Factors in Patients with Ulcerative Colitis |
| XU Li |
| Jiangsu Province People's Hospital, Jiangsu Nanjing 210029, China |
|
|
|
|
Abstract Objective: To analyze the effect of enteral spray of Kuijieling on the intestinal mucosal immune function and levels of inflammatory factors in patients with ulcerative colitis (UC).Methods: Ninety patients with UC were randomly divided into the experimental group (n=45) and the control group (n=45).The control group was treated with oral administration of sulfasalazinecapsule while the experimental group was additionally treated with enteral spray of Kuijieling. The relief of endoscopic ulcer, erosion and bleeding points was observed before and after treatment. The serum immunological and inflammatory factors, including immunoglobulins (IgG, IgM, IgA), T cell subsets (CD4+, CD8+), tumor necrosis factor α(TNF- α), interleukin -1β(IL-1β) were detected.Results: The results of endoscopy showed no significant differences between the two groups before treatment (P> 0.05). After treatment, the incidence rates of endoscopic ulcer, erosion and bleeding were significantly decreased (P< 0.05), and the incidence rates in experimental group (4.44%, 11.11%, 8.88%) were significantly lower than those in the control group (17.78%, 28.89%, 24.44%) (P< 0.05). Before treatment, the immunoglobulins, T cell subsetsand levels of serum inflammatory factors showed no significant differences between the two groups (P> 0.05). After treatment, the above indexes were significantly improved (P< 0.05), and the levels of IgG, IgM, IgA, CD8+, IL-4 and IL-10 in the experimental group were significantly higher than those in the control group while the levels CD4+, TNF- α and IL-1β were significantly lower than those in the control group (all P< 0.05).Conclusion: Enteral spray of Kuijieling can significantly enhance the clinical therapeutic effect of UC, relieve endoscopic ulcer and erosion, enhance theintestinal mucosal immune function and regulate the levels of inflammatory factors.
|
|
|
| Fund:江苏省卫生厅资助基金项目,(编号:20127802130) |
|
|
|
[1] 孙长贵.双歧三联活菌联合美沙拉嗪治疗老年溃疡性结肠炎的临床疗效及作用机制探讨[J].医学临床研究,2014,31(10):2060~2062.
[2] 王凤,吴秀美,甘丽萍,等.溃结灵对溃疡性结肠炎大鼠Th17分化的调节机制研究[J].中药药理与临床,2016,32(2):177~181.
[3] 姚宇亮.达克罗宁胶浆局部喷洒在内镜下结肠息肉电切术中的应用[J].四川医学,2015,36(4):536~538.
[4] 杨红,钱家鸣.炎症性肠病诊断与治疗的共识意见(2012年·广州)溃疡性结肠炎治疗部分解读[J].胃肠病学,2012,17(12):724~727.
[5] Bosani M,Ardizzone S,Porro GB,et al.Biologic targeting in the treatment of inflammatory bowel diseases[J].Biologics,2009,3(1):7.
[6] 沈浩.溃疡性结肠炎患者免疫功能状态的临床研究[J].现代消化及介入诊疗,2016,21(4):554~556.
[7] 孙显军.中药内服加保留灌肠治疗慢性非特异性结肠炎33例疗效观察[J].河北医学,2013,19(1):147~148.
[8] 周秋涛,胡剑峰.培菲康联合不同药物治疗溃疡性结肠炎的疗效及对NF-KB、TNF-α的影响[J].医学临床研究,2014,31(12):2364~2366.
[9] 徐进康,陆喜荣,徐宏伟,等.溃结灵对溃疡性结肠炎患者DNA酶Ⅰ、Fascin蛋白表达的影响[J].中医杂志,2013,54(1):45~47. |
|
|
|
2017, Vol. 23 
